Terms: = Ovarian cancer AND NAB2, MADER, 4665, ENSG00000166886, Q15742, MGC75085
4 results:
1. Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer.
Fairfield KM; Murray K; LaChance JA; Wierman HR; Earle CC; Trimble EL; Warren JL
Gynecol Oncol; 2014 Sep; 134(3):473-7. PubMed ID: 24952367
[TBL] [Abstract] [Full Text] [Related]
2. Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.
Madaras L; Baranyák Z; Kulka J; Szász AM; Kovács A; Lan PH; Székely B; Dank M; Nagy T; Kiss O; Harsányi L; Barbai T; Kenessey I; Tőkés AM
Pathol Oncol Res; 2013 Oct; 19(4):723-9. PubMed ID: 23709114
[TBL] [Abstract] [Full Text] [Related]
3. [The clinical features and management of borderline ovarian tumors].
Zhang Z; Hong W; Li L
Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):556-9. PubMed ID: 10806735
[TBL] [Abstract] [Full Text] [Related]
4. Endometrial carcinoma; ovarian dysfunction--a risk factor in young women.
Dahlgren E; Friberg LG; Johansson S; Lindström B; Odén A; Samsioe G; Janson PO
Eur J Obstet Gynecol Reprod Biol; 1991 Sep; 41(2):143-50. PubMed ID: 1936493
[TBL] [Abstract] [Full Text] [Related]
